Analyzing...
Transcript of Conference call with Analysts / Investors on Financial Results for the quarter and half year ended 30th September, 2023 In continuation of our letter dated 16-Oct-23 and pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Transcript of Conference call with Analysts / Investors on Financial Results of the Company for the quarter and half year ended 30th September, 2023, has been placed on the Company’s website at https://www.torrentpharma.com/pdf/investors/TorrentPharma-Earnings-23Oct-2023.pdf Kindly take note of the above.
Thanking you,